Skip to main content
Clinical Trials/NCT06446518
NCT06446518
Completed
N/A

A Randomized Control Trial for Assessing Virtual Reality for Perioperative Anxiolysis and Postoperative Pain Modulation in Adolescents Undergoing MIRPE Surgery

Semmelweis University1 site in 1 country50 target enrollmentAugust 17, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pectus Excavatum
Sponsor
Semmelweis University
Enrollment
50
Locations
1
Primary Endpoint
Change in anxiety
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

In this randomized control trial, investigators would like to assess as primary objective the effectiveness of VR in anxiolysis via using State Trait Anxiety- Inventory test various time during the perioperative period with recorded physiologic data. As a secondary objective they are investigating the use of VR in the postoperative period for pain modulation via using pain numeric rating scales (NRS), monitoring physiologic data, and collecting information on painkiller demand of the patients.

Detailed Description

This prospective, randomized controlled trial will be conducted with participants from the Paediatric Center, Semmelweis University, a tertiary level health care centre based in Budapest, Hungary. We evaluate the effects of VR immersion on reducing perioperative anxiety and postoperative pain. Participants will be asked to wear a VR headset for preferably an hour before and after the surgery. Patients will be asked to fill out three anxiety tests meanwhile investigators will record their vital parameters (HR, RR, SpO2, BP): on admission, in the operating room and on the surgical ward on the day after surgery. In the first postoperative day vital parameters, analgesic demand and NRS score will be recorded to follow patients pain status. Researchers will compare VR group to control group to see if anxiety and pain was different among those who recieved the VR headset.

Registry
clinicaltrials.gov
Start Date
August 17, 2022
End Date
December 10, 2024
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Agnes Jermendy MD PhD MPH

Professor of Pediatrics

Semmelweis University

Eligibility Criteria

Inclusion Criteria

  • Patient between 13-18 years old
  • reported chest deformity (pectus excavatum/ carinatum)
  • patients undergoing MIRPE surgery in general anesthesia
  • Hungarian fluency
  • willing to comply with study procedures.

Exclusion Criteria

  • gross cognitive impairment that would interfere with the ability to consent or complete study procedures.
  • Head injury
  • Head infection
  • Altered mental status (independently from midazolam)
  • Scabies or louse
  • Dizziness or vertigo
  • Blindness or severe vision loss
  • Lack of parental/ guardian or patient consent
  • Those, who has a head deformity, so VR headset does not fit well

Outcomes

Primary Outcomes

Change in anxiety

Time Frame: 1-2 days

Anxiety assessed by STAI-S and STAI-T questionnaires level of anxiety will be assessed using the State Trait Anxiety-Inventory. The test is composed of 2 parts: STAI-S (How does the patient feel right now?) and STAI-T (How does the patient feel on average?). Both questionnaires contain 20 questions with answers rating from 1 to 4.

Secondary Outcomes

  • Change in pain and vital parameters(1-2 days)

Study Sites (1)

Loading locations...

Similar Trials